secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001493152-26-021863
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech expects ~$4.2M gross from warrant inducement at $0.48/share; new warrants at $0.60
--------------------------------------------------------------------------------

- Existing warrants from May 2024, Sep 2024, Jul 2025 exercised at reduced exercise price of $0.48; gross proceeds ~$4.2M if fully exercised.
- New Class H inducement warrants at 200% coverage; exercise price $0.60, 5-year term, subject to stockholder approval.
- Placement agent: Ladenburg Thalmann; 8% cash fee, 6% warrant coverage, plus 0.75% management fee.
- Proceeds to be used for working capital and general corporate purposes.
- Company to call stockholder meeting within 75 days post-closing to approve issuance of Inducement Warrant Shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226021863/0001493152-26-021863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226021863/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer